Bath Savings Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,315
Closed -$216K 133
2019
Q1
$216K Sell
3,315
-50
-1% -$3.32K 0.05% 121
2018
Q4
$211K Sell
3,365
-1,170
-26% -$81.8K 0.05% 112
2018
Q3
$350K Sell
4,535
-670
-13% -$50.6K 0.08% 103
2018
Q2
$369K Sell
5,205
-2,545
-33% -$180K 0.09% 103
2018
Q1
$584K Sell
7,750
-625
-7% -$49.7K 0.15% 88
2017
Q4
$600K Buy
8,375
+95
+1% +$7.21K 0.15% 87
2017
Q3
$671K Sell
8,280
-410
-5% -$31.4K 0.18% 82
2017
Q2
$615K Sell
8,690
-3,440
-28% -$229K 0.17% 82
2017
Q1
$824K Sell
12,130
-19,075
-61% -$1.34M 0.24% 71
2016
Q4
$2.23M Sell
31,205
-6,920
-18% -$514K 0.69% 43
2016
Q3
$3.02M Sell
38,125
-980
-3% -$79.6K 0.94% 35
2016
Q2
$3.26M Buy
39,105
+1,390
+4% +$123K 1.02% 34
2016
Q1
$3.46M Buy
37,715
+2,022
+6% +$182K 1.12% 31
2015
Q4
$3.61M Buy
35,693
+2,676
+8% +$278K 1.21% 28
2015
Q3
$3.24M Buy
33,017
+4,029
+14% +$447K 1.15% 32
2015
Q2
$3.39M Buy
28,988
+6,826
+31% +$746K 1.16% 31
2015
Q1
$2.17M Buy
22,162
+7,384
+50% +$750K 0.73% 39
2014
Q4
$1.39M Buy
14,778
+6,240
+73% +$645K 0.48% 55
2014
Q3
$909K Buy
+8,538
New +$836K 0.34% 61

Other funds holding GILD

Bath Savings Trust's GILD Position: Q2 2019 in Review

Bath Savings Trust sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 3,315 shares — an estimated $216K sold.

Bath Savings Trust first reported a position in GILD in Q3 2014 and held it in 19 quarters. The position peaked at $3.61M in Q4 2015. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • Bath Savings Trust reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
  • Bath Savings Trust sold 3,315 Gilead Sciences shares in Q2 2019, an estimated $216K.
  • Bath Savings Trust first reported a position in Gilead Sciences in Q3 2014 and held it in 19 quarters.
  • Bath Savings Trust's Gilead Sciences position peaked at $3.61M in Q4 2015.
  • 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Bath Savings Trust's 13F filing for Q2 2019, filed 1 Jul 2019.